Poly-MVA: An Integrative Approach to Specific Cancers – Case Studies

CLICK HERE FOR PRESENTATION SLIDES FOR THIS WEBCAST [display_podcast] Dr. Shari Lieberman discusses published case studies on the use of palladium lipoic complexes (LAPd) in multiple myeloma and non-small cell lung cancer. LAPd is the complex available commercially as Poly-MVA, a unique nutritional supplement that assists in boosting immune response, healing damaged cells and providing energy for compromised body systems. Shari Lieberman, Ph.D., C.N.S., F.A.C.N., is a research scientist and industry consultant based in New York City and Pompano Beach, Florida. She is also the Founding Dean of New York Chiropractic College’s (Seneca Falls, New York) MS Degree Program in Clinical Nutrition. Poly-MVA is a promising new, non-toxic dietary supplement that may assist in boosting immune response, and healing damaged cells. It is a uniquely formulated nutritional supplement containing a proprietary blend of Palladium and Alpha Lipoic Acid, Vitamins B1, B2 and B12, Formylmethionine, Acetyl Cystiene, and trace amounts of Molybdinum, Rhodium, and Ruthenium. While definitive studies on it’s effect in human nutrition and health are under way, early studies and anecdotal information indicate that the active ingredients in palladium lipoic complex may be beneficial in protecting cell DNA and RNA, assisting the body produce energy, and provide support to the liver in removing harmful substances from the body. Some studies indicate that ingredients of Poly-MVA can assist in preventing cell damage, and removing heavy metals from the bloodstream. As a powerful antioxidant, it can help to neutralize the free radicals within the body that are thought to influence the aging processes and convert them into energy. Other ingredients are involved in DNA synthesis, production of the myelin sheath that protects nerves, and red blood cell production, and playing an important role in immune and nerve function.